Dr. Carl Jan Gilmore, MD

Dr. Gilmore practices at New Mexico Orthopaedic Associates in Rio Rancho, New Mexico.

Dr. Gilmore's NPI, 1003012493, was assigned on June 22, 2007. Dr. Gilmore graduated from University of New Mexico School of Medicine in 2007. Dr. Gilmore holds New Mexico license RS20070318.

Dr. Gilmore's primary practice is New Mexico Orthopaedic Associates, at 2101 Unser SE Blvd, Rio Rancho, NM 87124 in Sandoval County. The practice phone is (505) 892-3520.

Dr. Gilmore's primary practice is New Mexico Orthopaedic Associates in Rio Rancho, New Mexico. Dr. Gilmore is also affiliated with Presbyterian Hospital. The medical group on file is Presbyterian Medical Group. Dmand AI also links Dr. Gilmore to 1 more group practice or clinic, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gilmore practices, 3 sites in all. Vendor and product names are available with a free account.

Orthopaedic surgery is Dr. Gilmore's primary specialty in the NPI Registry, under taxonomy code 207X00000X. Dr. Gilmore is board certified in orthopaedic surgery by the American Board of Orthopaedic Surgery. Dr. Gilmore is licensed in New Mexico.

CMS data shows 4,394 Medicare services from Dr. Gilmore across 14 procedure codes in 2024, for 490 Medicare patients. Medicare paid $142,006 for them.

CMS counts 490 Medicare patients who saw Dr. Gilmore in 2024. The largest group is 65 to 74, with 280 patients. 75% of them have arthritis, and 65% have high cholesterol. 5% are also on Medicaid. Their average risk score is 0.85, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Gilmore's median patient age at 67, with 57% women.

In 2024, Dr. Gilmore wrote 536 Medicare Part D claims for 198 patients. 99% of them were for generic drugs. CMS names the drug for 460 of them, across 7 drugs with 11 or more claims each, at $5,324 in total drug cost. In 2023, CMS named 541 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 76 out of 100 for Dr. Gilmore for performance year 2024, reported individually. Dr. Gilmore accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 58 procedures of knee replacement by Dr. Gilmore, more than 83% of the clinicians it reports for that procedure.

Lower limb (leg) arthroscopy (minimally invasive joint repair): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links Dr. Gilmore to 10 clinical trials, 4 of them phase 2 studies. 9 are still active or recruiting. Conditions studied include Adenocarcinoma of Lung, Biliary Atresia and Low Back Pain.

CMS Open Payments shows 62 general payments to Dr. Gilmore from 7 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 41% of the total. Arthrex, Inc. paid the most, $1,712.

Dr. Gilmore graduated from University of New Mexico School of Medicine in 2007.